Inhalon Biopharma

Carrboro, United States

Inhalon Biopharma is a bio-tech company which is into research & development of monoclonal antibodies.

Nov 2022

Grant

Top Investors

Berkeley Catalyst Fund (BCF)Sand Hill AngelsLife Science AngelsCollaboratoryU.S. Army Medical Research & Development Command

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Inhalon Biopharma

Who are Inhalon Biopharma's investors?

Inhalon Biopharma's investors include Berkeley Catalyst Fund (BCF), Sand Hill Angels, Life Science Angels, Collaboratory, U.S. Army Medical Research & Development Command.

Where is Inhalon Biopharma headquartered?

Inhalon Biopharma is headquartered in Carrboro, United States.

What does Inhalon Biopharma do?

Inhalon Biopharma is a bio-tech company which is into research & development of monoclonal antibodies.

What stage is Inhalon Biopharma at?

Inhalon Biopharma is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 8, 2022.

MLA

"Inhalon Biopharma — Funding & Investors." VCBacked, November 8, 2022, https://www.vcbacked.co/company/inhalon-biopharma. Accessed July 1, 2026.

APA

VCBacked. (2022). Inhalon Biopharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/inhalon-biopharma

Wikipedia (cite web)

{{cite web |title=Inhalon Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/inhalon-biopharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 8, 2022.